Loading stock data…
agilon health, inc. (AGL)
$91.37+2.87 (+3.24%)
After Hours$91.37+0.00 (+0.00%)· Last close Sep 8
agilon health, inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
agilon health, inc. in the Healthcare sector is trading at $91.37 with a market capitalization of $1.5B. Wall Street consensus targets $115.08 (13 analysts), implying a +25.9% move over the next 12 months. The stock is currently 31% below its 52-week high of $133.04, remaining 76.0% above its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +25.9% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.49B↑ | $1.42B↓ | $1.57B↑ | $1.44B↑ | $1.39B |
| Gross Profit | $107.14M↑ | $65.02M↑ | -$90.67M↓ | -$67.65M↓ | -$52.43M |
| Operating Income | $11.77M↑ | $4.00M↑ | -$157.74M↓ | -$131.27M↓ | -$116.03M |
| Net Income | $17.96M↓ | $48.92M↑ | -$188.88M↓ | -$110.21M↓ | -$104.37M |
Peer Comparison
JNJUNHPFE
Fundamentals
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-mon...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.49B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
3.04
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-102.06%
Volume
Today's trading volume
148,220
Recent News
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?
Here is how Agilon Health (AGL) and Illumina (ILMN) have performed compared to their sector so far this year.
Q2 Earnings Highlights: agilon health (NYSE:AGL) Vs The Rest Of The Outpatient & Specialty Care Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at agilon health (NYSE:AGL) and the best and worst performers in the outpatient & specialty care industry.
5 Insightful Analyst Questions From agilon health’s Q2 Earnings Call
Agilon Health’s second quarter was marked by significant beats on both revenue and profitability, but the results did not prevent a notable drop in the company’s share price. Management attributed the quarter’s strong financials to operational improvements, including earlier identification of high-risk conditions and expanded adoption of clinical pathways, especially in chronic heart failure management. CEO Tim O’Rourke emphasized that these changes are structural rather than short-term fixes, n
Agilon Health (AGL) Q2 2026 Earnings Call Transcript
Revenue hit $1.49 billion as medical margins swung sharply positive.
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year?
Here is how Agilon Health (AGL) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.